-
1مؤتمر
المؤلفون: Andrey Kulikov (4871602), Elena Shipaeva (11258712), Anastasia Dmitrieva (11258715), Vera Batrak (267991), Georgy Shipunov (11258718), Colin Guy (3136320), Jill Smith (2694001), Ran Zhang (117374), Michael Zhang (196907), Jeff Duan (11258721), Anton Chestukhin (11258724), Sergei Barbashov (11258727), Mikhail Samsonov (11258730), Yan Lavrovsky (2390548)
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, cancer immunotherapy, monoclonal antibody, PD-L1, in vitro efficacy, animal models, therapeutic agent
-
2مؤتمر
المؤلفون: Andrey Kulikov, Elena Shipaeva, Anastasia Dmitrieva, Vera Batrak, Georgy Shipunov, Colin Guy, Jill Smith, Ran Zhang, Michael Zhang, Jeff Duan, Anton Chestukhin, Sergei Barbashov, Mikhail Samsonov, Yan Lavrovsky
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, cancer immunotherapy, monoclonal antibody, PD-L1, in vitro efficacy, animal models, therapeutic agent
الإتاحة: https://doi.org/10.3389/fphar.2021.723038.s001Test
https://figshare.com/articles/presentation/Presentation1_Preclinical_Characterization_of_a_Novel_Anti-Cancer_PD-L1_Inhibitor_RPH-120_pptx/15146868Test